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Abstract
A disintegrin and metalloprotease 10 (ADAM10) is a key regulator of cellular processes by shedding extracellular domains of
transmembrane proteins. We have previously demonstrated that deletion of B cell expressed ADAM10 results in changes in
lymphoid tissue architecture and impaired germinal center (GC) formation. In this study, mice were generated in which
ADAM10 is deleted in B cells following class switch recombination (ADAM10D/DIgG1-cre+/2 mice). Despite normal GC
formation, antibody responses were impaired in ADAM10D/DIgG1-cre+/2 mice, implicating ADAM10 in post-GC and
extrafollicular B cell terminal differentiation. Surprisingly, plasma cell (PC) numbers were normal in ADAM10D/DIgG1-cre+/2
mice when compared to controls. However, PCs isolated from ADAM10D/DIgG1-cre+/2 mice exhibited decreased expression
of transcription factors important for PC function: Prdm1, Xbp1 and Irf4. Bcl6 is a GC transcriptional repressor that inhibits
the PC transcriptional program and thus must be downregulated for PC differentiation to occur. Bcl6 expression was
increased in PCs isolated from ADAM10D/DIgG1-cre+/2 mice at both the mRNA and protein level. These results demonstrate
that ADAM10 is required for proper transcription factor expression in PCs and thus, for normal PC function.
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Introduction
Key features of antibody-mediated immune responses are the
generation of antigen-specific plasma cells (PCs) and memory B
cells. Plasma cells (PCs) are antibody factories and memory B cells
can rapidly differentiate into PCs after reencountering antigen.
Two general types of PCs are known. Short-lived PCs arise from
extrafollicular responses while long-lived PCs are derived primar-
ily from germinal center (GC) B cells [1,2]. Within GCs, antigen-
activated B cells undergo class-switch recombination (CSR),
somatic hypermutation (SHM) and affinity maturation [3]. The
transition from GC B cell to PC requires changes in the
transcriptional program. The transcription factors that are
generally required for PC differentiation are B lymphocyte-
induced maturation protein 1 (Blimp1), interferon regulatory
factor 4 (IRF4) and X-box binding protein 1 (Xbp1) [4–7]. GC B
cells express Bcl6, a known suppressor of Prdm1, the gene encoding
Blimp1. Moreover, Blimp1 is also able to repress Bcl6. Therefore,
as long as Bcl6 is expressed in GC B cells, Blimp1 expression and
plasmacytic differentiation are inhibited. If Blimp1 is expressed,
however, Bcl6 will be repressed thus allowing for PC differentiation
to occur [8–10]. Therefore, downregulation of Bcl6 and Blimp1
upregulation is essential for PC differentiation and optimal
humoral responses [1,2,11]. Consistent with this idea, study of
transgenic mice that constitutively express Bcl6 in B cells showed a
decreased number of class-switched PCs [3,12].
ADAMs (A disintegrin and metalloproteases) are membrane-
bound proteins that mediate ectodomain shedding and regulated
intramembrane proteolysis (RIP) of transmembrane proteins.
Ectodomain shedding releases soluble fragments into the extra-
cellular space, possibly downregulating events that depend on
transmembrane receptor expression or activating paracrine
signaling by soluble products derived from ADAMs’ substrates.
ADAMs carry out a wide range of functions, including but not
limited to, paracrine signaling, cell adhesion, and intracellular
signaling [4–7,13]. ADAM10 is a proteolytically active ADAM
family member that is critical for many important biological
processes [8–10,14]. Furthermore, as recently described, the
intracellular domain of ADAM10 can itself be shed, allowing for
the ADAM10 intracellular domain (ICD) to translocate to the
nucleus and modulate gene expression [15].
ADAM10 is a key regulator of lymphocyte development [16].
We and others have demonstrated that ADAM10 is essential for T
cell and marginal zone B cell development [17,18]. We recently
published that ADAM10 is highly expressed in GC B cells.
Interestingly, mice that lack ADAM10 in all peripheral B cells
(ADAM10B2/2 mice) fail to generate GCs and have severely
impaired humoral responses. Furthermore, the defects in antibody
production are accompanied by changes in lymphoid architecture
[19]. Whether the defects in GC formation and antibody
production observed in ADAM10B2/2 mice are secondary to
the changes in lymphoid architecture or whether ADAM10 plays a
role in GC formation and/or antibody production independently
of these changes remains to be determined.
In order to investigate the involvement of ADAM10 in PC
development and function, ADAM10 was deleted post-isotype
switching by crossing ADAM10-floxxed (ADAM10D/D) mice with
IgG1-cre+/2 mice [20]. In this situation, GCs would form prior to
ADAM10 deletion. Here we demonstrate that these recently
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generated mice showed no alteration in lymphoid architecture
and/or GC development. Intriguingly, humoral responses to T-
dependent and T-independent antigens were still clearly impaired
in ADAM10D/DIgG1cre+/2 mice, implicating ADAM10 in B cell
terminal differentiation. Furthermore, we show that in spite of
normal PC numbers, mRNA expression levels of transcription
factors important for PC development, Prdm1, xbp1 and Irf4 were
altered in PCs isolated from ADAM10D/DIgG1cre+/2 mice. In
addition, the GC transcription factor Bcl6 was elevated at both the
message and protein level. These results demonstrate that
ADAM10 is required for proper PC function.
Results
Generation of ADAM10D/DIgG1+/2 mice
Members of the ADAM family regulate a variety of functions,
including, but not limited to, cell migration, proliferation and
adhesion [13]. We previously generated mice that lacked
ADAM10 in all peripheral B cells (ADAM10B2/2 mice) by
crossing a transgenic mouse strain containing loxP sites surround-
ing exon 9 of adam10 (ADAM10D/D) allele with mice expressing
Cre recombinase under the control of the CD19 promoter [17].
Study of these mice demonstrated a severe defect in GC formation
and changes in lymphoid architecture [19]. In order to determine
whether ADAM10 plays a role in PC development or if the
impairment in antibody production observed in ADAM10B2/2
mice was secondary to changes in architecture, we crossed
ADAM10D/D mice with IgG1-cre transgenic mice and generated
ADAM10D/DIgG1-cre+/2mice [20]. Previous studies have dem-
onstrated that the IgG1-cre transgene shows specificity for GC B
cells, with approximately 75% of GC B cells expressing Cre
recombinase. Introduction of the IgG1-cre transgene has been
shown to affect IgG1 production; therefore, we also generated
controls that have Cre expression but lack ADAM10-floxxed
alleles (ADAM10+/+IgG1-cre+/2 mice). In order to track cells that
had undergone cre-mediated recombination, we crossed
ADAM10D/DIgG1-cre+/2 and ADAM10+/+IgG1-cre+/2 mice
with R26R-EYFP+ mice, thus, generating ADAM10D/DIgG1-
cre+/2R26R-EYFP+ (ADAM10D/DIgG1-cre+/2YFP+) and AD-
AM10+/+IgG1-cre+/2YFP+ (control) mice that express EYFP
transgene following cre-mediated recombination [17].
Antibody production and GC formation in ADAM10D/
DIgG1-cre+/2YFP+ mice
Our previous study demonstrated that ADAM10-deletion in all
peripheral B cells (ADAM10B2/2 mice) led to severe impairments
in antibody production, as evidenced from decreased antibody
responses to T-dependent antigens. Moreover, GC formation was
severely affected in these mice. Furthermore, follicular helper T
cell (TFH) numbers were also diminished in ADAM10
B2/2 mice
[19]. In order to determine if deletion of ADAM10 in class-
switched cells affected basal antibody levels, mice were bled and
IgM, IgG1 and IgE levels were measured by ELISA. As depicted
in Figure 1, no differences were seen between ADAM10D/DIgG1-
cre+/2YFP+ and controls.
In order to determine whether deletion of ADAM10 within
GCs affected GC maintenance and the production of antigen-
specific antibodies, ADAM10D/DIgG1-cre+/2 mice and controls
were immunized with 10 mg of NP-KLH emulsified in alum. The
proportion of GC B cells, defined as B220+GL7+Fashi, was
quantified by flow cytometry 14 days post-immunization. The
percentage of GC B cells was comparable between ADAM10D/
DIgG1-cre+/2YFP+ and controls (Figure 2A,B). Immunohisto-
chemistry analysis also showed normal GCs, defined as clusters of
GL7+ within B cell follicles (Figure 2C). Moreover, the
appearance of B cell follicles was comparable to that of controls
(Figure 2C).
Interestingly, despite normal GC B cell numbers, while antigen-
specific IgM levels were comparable to control mice (Figure 3A),
antigen-specific IgG1 was significantly reduced (Figure 3B).
Moreover, mice were also immunized with 100 mg of NP-LPS, a
T-independent antigen. Antibody responses to this antigen were
also impaired (Figure 3C–D). These results demonstrate a defect in
class-switched antibody production in ADAM10D/DIgG1-cre+/2
mice.
Memory B cell development and recall antibody
responses in ADAM10D/DIgG1-cre+/2YFP+ mice
Given that ADAM10D/DIgG1-cre+/2 mice showed abnormal
primary antibody responses, we sought to determine whether
recall antibody responses were also impaired. To this end, mice
were immunized with 10 mg of NP-KLH emulsified in alum and
boosted 6 weeks later. As demonstrated in Figure 3, ADAM10D/
DIgG1+/2 mice showed decreased production of antigen specific
IgG1-antibodies following primary immunization. Moreover,
recall responses were also dramatically impaired (Figure 4A).
Interestingly, when the frequency of memory B cells was analyzed
by flow cytometry 14 days following immunization, ADAM10D/
DIgG1+/2 mice had memory B cells percentages comparable to
that of controls (Figure 4B,C). These data also suggest that the
defects seen in secondary antibody responses result from impaired
PC differentiation and/or function.
Plasma cell development in ADAM10D/DIgG1-cre+/2YFP+
mice
Given that ADAM10D/DIgG1-cre+/2YFP+ mice had impaired
antibody responses but normal GCs, we hypothesized that the
defect in antibody production resulted from aberrant PC
differentiation. CD138 is marker for antibody-secreting PCs
(B220lo/2CD138+ cells). Accordingly, ADAM10D/DIgG1-cre+/
2YFP+ and control mice were immunized with 10 mg of NP-
KLH and the percentage of Cre-expressing PCs (B220lo/
2CD138+YFP+ cells) in the spleen, peripheral blood and bone
marrow was determined (Figure 5) [7]. The gating protocol is
depicted in Figure 5A. Surprisingly, although ADAM10D/DIgG1-
cre+/2YFP+ mice had markedly impaired antigen-specific IgG1
responses, they had PC percentages comparable to that of controls
(Figure 5B–D). Previous studies revealed a similar phenotype
when humoral responses were studied in B-cell specific XBP1-
deficient mice [21]. XBP-1 is a protein involved in ER-stressed
and is required for antibody-secretion [21]. These data suggested
that ADAM10 might regulate antibody production by modulating
XBP-1 expression in PCs.
Abnormal gene expression in plasma cells isolated from
ADAM10D/DIgG1-cre+/2YFP+ mice
Given that the phenotype observed in ADAM10D/DIgG1-cre+/
2YFP+ mice resembled that of B-cell specific XBP1-deficient mice,
Xbp1 levels were determined in PCs isolated from ADAM10D/
DIgG1-cre+/2YFP+ and control mice. Interestingly, Xbp1 message
levels were significantly reduced when compared to controls
(Figure 6A). Studies have demonstrated that Xbp1 expression is
preceded by the downregulation of Bcl6 and the increased
expression of Blimp1 and IRF4 [21]. Thus, the expression of
these genes was examined. PCs isolated from ADAM10D/DIgG1-
cre+/2YFP+ mice also showed a reduction in message levels for
Prdm1 (the gene encoding for Blmp1) (Figure 6B) and Irf4
ADAM10 and Plasma Cell Function
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(Figure 6C). Moreover, Bcl6 levels were significantly higher than
in control PCs (Figure 6D). Even more striking, while PC isolated
from controls had ,60 fold more Prdm1 message than Bcl6, PCs
isolated from ADAM10D/DIgG1-cre+/2YFP+ mice showed only
,3 fold more Prdm1 than Bcl6 (Figure 6E). These results
demonstrate that ADAM10 is required for the proper downreg-
ulation of Bcl6 and upregulation of Prdm1, Irf4 and Xbp1, and thus
for optimal PC function and production of class-switched
antibodies.
Consistent with the gene expression results, flow cytometry
analysis revealed the presence of a B220lo/2CD138+Bcl6+
population in the spleens of ADAM10D/DIgG1-cre+/2 mice
following immunization. Splenocytes were isolated and stained
for B220 and CD138 (Figure 7A). B220lo/2CD138+ cells were
analyzed for non-specific (isotype) or Bcl6-specific staining
Figure 1. ADAM10D/DIgG1-cre+/2 mice have normal basal antibody levels. Serum (A) IgM, (B) IgG1, and (C) IgE were measured by capture
ELISA from 8- to 12-wk-old mice. ns: non significant.
doi:10.1371/journal.pone.0042694.g001
Figure 2. ADAM10D/DIgG1-cre+/2 mice have normal germinal center formation. ADAM10D/DIgG1-cre+/2 (&) and controls (%) were
immunized with NP-KLH emulsified in alum. Fourteen days post-immunization GC formation was assessed by flow cytometry and
immunohistochemistry. (A) Representative dot plot (gated on B220+ cells). (B) Frequency of GC B cells of total B cells, representative of 5 mice
per group from at least two independent studies. (C) Representative splenic sections stained with GL7 (green) and IgD (red). ns: non significant.
doi:10.1371/journal.pone.0042694.g002
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Figure 3. ADAM10D/DIgG1-cre+/2 mice show impaired primary antibody responses. ADAM10D/DIgG1-cre+/2 (&) and controls (%) were
immunized with a T-dependent antigen, NP-KLH, emulsified in alum (A–B) or a T-independent antigen, NP-LPS (C–D). At the indicated times, serum
samples were collected and NP-specific antibodies were measured by capture ELISA. Bars represent the mean 6 SE of 5–9 mice per group (*p,0.05,
**p,0.01). Data represent results obtained in at least two independent experiments.
doi:10.1371/journal.pone.0042694.g003
Figure 4. ADAM10D/DIgG1-cre+/2 mice show impaired recall antibody responses but normal memory B cell development. (A)
ADAM10D/DIgG1-cre+/2 (&) and controls (%) were immunized with NP-KLH emulsified in alum. At the indicated times serum samples were collected
and NP-specific antibodies were measured by capture ELISA. Mice were challenged with NP-KLH in alum 6 weeks following primary immunization.
Bars represent the mean 6 SE of 5–9 mice per group (*p,0.05, **p,0.01). Data represent results obtained in at least two independent experiments.
(B–C) ADAM10D/DIgG1-cre+/2 (&) and controls (%) were immunized with NP-KLH emulsified in alum. Fourteen days following immunization, spleens
were harvested and memory B cell numbers were analyzed. Memory B cells were defined as B220+IgMlo/2IgG1+CD38+ [44].(B) Representative dot plot
(gated on B220+IgMlo/2 cells). (C) Frequency of memory B cells of total B220+IgMlo/2 cells, representative of 5 mice from at least two independent
studies. ns: non significant.
doi:10.1371/journal.pone.0042694.g004
ADAM10 and Plasma Cell Function
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(Figure 7B,C). Quantified results are displayed in Figure 7D.
These results demonstrate that in the absence of ADAM10, Bcl6 is
overexpressed at both the message and protein level.
Discussion
Members of the ADAM family regulate a wide range of
functions, including cell migration, proliferation and adhesion
[22]. ADAM10, in particular, has been recently shown to be
critical for lymphocyte development through initiation of the
canonical Notch signaling pathway [17,18]. We recently published
that ADAM10 is highly expressed in GC B cells. Interestingly,
mice that lacked ADAM10 in all peripheral B cells fail to generate
GCs and have severely impaired humoral responses. Furthermore,
defects in antibody production are accompanied by changes in
lymphoid architecture [19]. Here we demonstrate that mice with
ADAM10 deletion in class-switched B cells (ADAM10D/DIgG1-
cre+/2 mice) have normal GC formation and show no changes in
splenic architecture. These mice, however, showed reduced
production of class-switched antibodies. Given that Cre under
the control of the IgG1 promoter is preferentially expressed in
class-switched cells, the current study does not allow us to
determine the role of ADAM10 in IgM-producing cells. As
summarized in Figure 8, we have demonstrated that in spite of
normal PC percentages, expression levels of proteins important for
PC development, Prdm1, xbp1 and Irf4 were diminished compared
to controls. In addition, the GC transcription factor Bcl6 was not
properly downregulated in ADAM10D/DIgG1cre+/2 mice. These
results demonstrate that ADAM10 is required for the appropriate
downregulation of Bcl6 and upregulation of Prdm1, Irf4 and Xbp1.
Subsequently, antibody responses are abnormal in ADAM10D/
DIgG1cre+/2 mice. Thus, ADAM10 is important for proper PC
function.
The transcription factor Bcl6 is necessary for GC formation and
B cell proliferation. While it is well established that Bcl6 must be
downregulated for class-switched PC differentiation to occur, the
factors mediating this event are not fully understood [12]. It has
been previously demonstrated that Stat3 activated by IL-21 can
trigger Blimp1 expression by competing with Bcl6 for DNA
binding sites [9]. Moreover, it has been proposed that B cell
receptor (BCR) and CD40 signaling lead to Bcl6 degradation [23].
Recent studies demonstrated that ectopic Stat3 signaling could
induce Blimp1 expression, even in the presence of high Bcl6 levels;
however, PC differentiation did not proceed until Bcl6 levels were
reduced [9]. Here we demonstrate that ADAM10 is important for
Bcl6 downregulation and ADAM10 deficiency leads to impaired
antibody responses.
Along with defective Bcl6 downregulation observed in AD-
AM10-deficient PCs, ADAM10 deletion also resulted in decreased
levels of Prdm1, Irf4 and Xbp1. Blimp1 and IRF4 lead to cell cycle
arrest and promote PC differentiation [24], while XBP1 is
required for endoplasmic reticulum (ER) expansion and immu-
noglobulin production and secretion [25]. It has been very well
documented that Bcl6 can inhibit Blimp1 [26]. Moreover, Blimp1
and IRF4 permit XPB1 expression [7,25]. It is possible that
ADAM10 is involved in a pathway that controls both Blimp1 and
Figure 5. ADAM10D/DIgG1-cre+/2 mice have normal plasma cell numbers. ADAM10D/DIgG1-cre+/2 (&) and controls (%) were immunized
with NP-KLH emulsified in alum. Twenty-one days following immunization, tissues were harvested and PC numbers were analyzed. Cre-expressing
plasma cells were defined as B220lo/2CD138+YFP+. (A) Representative FACS staining of ADAM10D/DIgG1-cre+/2 and controls. Frequency of plasma
cells of total B220lo/2 cells from (B) spleen, (C) peripheral blood and (D) bone marrow. Bars represent the mean 6 SE of 4–5 mice per group. Data
represent results obtained in at least two independent experiments.
doi:10.1371/journal.pone.0042694.g005
ADAM10 and Plasma Cell Function
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IRF4 expression, and decreased Blimp1 and IRF4 then leads to
decreased XBP1 expression.
Bcl62/2 mice respond normally to T-independent antigens,
demonstrating that Bcl6 is dispensable for T-independent antibody
responses. On the other hand, studies have demonstrated that PC
differentiation following T-independent immunizations is depen-
dent on Blimp1 expression [4,27,28]. Recent studies have
demonstrated that through dual BCR and toll like receptor
(TLR) engagement, NP-LPS induces T-independent isotype
switching [29]. Interestingly, when ADAM10D/DIgG1cre+/2 mice
where immunized with NP-LPS, a T-independent antigen that
activated B cells through Toll like receptor 4 (TLR4) signaling,
impaired antibody production was also evident. It is therefore
possible that ADAM10 deletion leads to decreased Blimp1, Xbp1
and Irf4 expression in a Bcl6-independent manner. Remarkably,
studies of mice deficient in a TLR4 downstream signaling
molecule, MyD88, demonstrated that MyD88-deficient B cells
also exhibited enhanced Bcl6 expression and diminished Blimp1
expression [30], suggesting that ADAM10 might be involved in
TLR4-signaling.
ADAM10 is critical for Notch1 and Notch2 cleavage and the
initiation of the canonical Notch signaling pathway [17,18]. The
role of Notch signaling in GC formation and PC differentiation,
however, remains controversial. In vivo studies of B cell specific
RBP-Jk-deficient mice, a key mediator of Notch signaling, failed to
reveal a defect in antibody production [31]. Consistent with this
finding, a recently published report demonstrated that B cell-
specific Notch2-deficient mice have normal GC formation and
normal numbers of splenic PCs [32,33]. Moreover, mice with
constitutively active Notch2 intracellular domain exhibited
diminished antibody responses to T-dependent and T-indepen-
dent antigens and impaired GC formation [34]. On the other
hand, in vitro studies have demonstrated that Notch signaling
enhances B cell activation and supports B cell survival [35].
Moreover, recent studies have shown that Notch signaling
synergizes with BCR and CD40 signaling to enhance murine B
Figure 6. Plasma Cells from ADAM10D/DIgG1-cre+/2 mice have
altered gene expression. ADAM10D/DIgG1-cre+/2 and controls were
immunized with NP-KLH emulsified in alum. Twenty-one days following
immunization, splenic PCs were isolated via magnetic bead isolation.
mRNA was isolated and (A) Xbp1 (B) Prdm1, (C) Irf4 and (D) Bcl6 message
levels were determined by qPCR. (E) The ratio of Prdm1 to Bcl6 was
calculated. Bars represent the mean 6 SE of 3 independent studies;
cells from 3 mice from each genotype pooled in each study. (*p,0.05,
**p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0042694.g006
Figure 7. Plasma cells isolated from ADAM10D/DIgG1-cre+/2 mice express Bcl6. ADAM10D/DIgG1-cre+/2 and controls were immunized with
NP-KLH emulsified in alum. Twenty-one days following immunization, splenic plasma cells were analyzed by Bcl6 protein expression via flow
cytometry. (A) Plasma cells were defined as CD138+B220lo/2. After gating on these cells, they were analyzed for (B) non-specific (isotype) or (C) Bcl6-
specific staining. (D) Frequency of Bcl6+ cells of plasma cells. Bars represent the mean 6 SE of 4–5 mice. (**p,0.01).
doi:10.1371/journal.pone.0042694.g007
ADAM10 and Plasma Cell Function
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cell activation [36]. Further studies will be needed, however, in
order to elucidate Notch1 and Notch2’s role in PC formation and
whether the phenotype observed in ADAM10D/DIgG1-cre+/
2YFP+ mice results from impaired Notch signaling.
Another ADAM10 substrate is the IL-6 receptor [37]. Studies
have demonstrated that IL-6 signaling can induce Bcl6 expression
[38,39]. In the context of a GC, IL-6 is produced by activated
FDCs and promotes SHM, affinity maturation, and CSR [40].
Indeed, IL-6-deficient mice showed decreased SHM following T-
dependent immunization [40]. Given that ADAM10 is responsible
for the cleavage of the IL-6 receptor (IL-6R) [37], one could
speculate that increased IL-6R expression could lead to increased
IL-6 signaling, thus, leading to Bcl6 overexpression. Moreover, it is
possible that by modulating IL-6R expression levels, ADAM10
can influence SHM and affinity maturation and CSR.
Regulation of Notch signaling is not the only way that
ADAM10 is capable of modulating gene expression. Recent
experiments have demonstrated that ADAM10 not only mediates
RIP, but it is also subject to RIP. ADAM9 and ADAM15 have
been identified as the proteases responsible for releasing the
ADAM10 ectodomain, while gamma-secretase mediates the
release of the ADAM10 intracellular domain (ICD). ADAM10-
ICD then translocates to the nucleus and modulates gene
expression [15]. Studies have demonstrated that nuclear ADAM10
can interact with androgen receptors and act like a transcription
factor [41]. It is thus possible that ADAM10 regulates gene
expression and PC differentiation, not by shedding of membrane
proteins but through its involvement in gene regulation.
ADAM10-ICD regulation of gene expression will require further
study.
In conclusion, here we demonstrate that deletion of ADAM10
in class-switched cells does not impair GC formation. However,
despite normal PC frequencies, ADAM10D/DIgG1-cre+/2YFP+
mice showed impaired antibody responses to T-dependent and T-
independent antigens. Gene expression analysis demonstrated that
PCs isolated from ADAM10D/DIgG1-cre+/2YFP+ mice expressed
lower levels of Prdm1, Irf4 and Xbp1. Intriguingly, ADAM10D/
DIgG1-cre+/2 PCs also expressed 3-fold higher levels of Bcl6.
These results demonstrate that ADAM10 is important for the
expression of transcription factors that are required for PC
differentiation and thus, for optimal antibody production.
Materials and Methods
Mice and immunizations
To generate ADAM10D/DIgG1-cre+/2YFP+ mice, ADAM10D/
DYFP+ mice were crossed with IgG1-cre+/2 mice (Jackson Mice)
[19,42]. ADAM10+/+IgG1-cre+/2YFP+ mice were used as con-
trols. All mouse protocols were approved by the Virginia
Commonwealth University Institutional Animal Care and Use
Committee. Immunizations comprised of injections of 10 mg 4-
Hydroxy-3-nitrophenylacetyl coupled to keyhole limpet hemocy-
anin at a ratio of 27:1 (NP27KLH, referred to as NP-KLH) in
4 mg of alum or 100 mg of NP-LPS in PBS (Biosearch
Technologies). For recall responses to NP-KLH, mice were
Figure 8. Model.Wild type plasma cells express higher levels of Blimp1, IRF4 and XBP1, while Bcl6 is repressed. This allows for antibody secretion. In
the case of ADAM10D/DIgG1-cre+/2 mice, Bcl6 levels are higher than seen in wild type. Moreover, Blimp1, IRF4 and XBP1 expression are decreased,
leading to impaired antibody secretion.
doi:10.1371/journal.pone.0042694.g008
ADAM10 and Plasma Cell Function
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boosted 6 weeks post-primary immunization with the same dose of
antigen as primary immunization.
Flow cytometry and immunohistochemistry
Single cell suspension of splenocytes were stained as described
previously [19]. Abs included anti-mouse unlabeled 2.4G2, FITC
conjugated GL7 (GL7); PE-Cy7 conjugated B220 (RA3-6B2) and
CD38 (90); allophycocyanin-conjugated GL7 (GL7) and CD138
(281-2); PE-conjugated IgD (11-26c.2a), Fas (Jo2) and PerCP-
Cy5.5 conjugated IgM. Flow cytometry analysis was performed
using a Canto or Aria II (BD Biosciences), and data analysis was
conducted with FlowJo v8.8.7 (Tree Star). Lymphocytes were
gated based on FSC vs. SSC. B cell subsets were defined as follows:
Plasma cells: B220lo/2CD138+ [21]; germinal center B cells:
B220+GL7+Fashi [43]; and memory B cells: B220+IgMlo/
2IgG1+CD38+ [44]. For immunohistochemistry, spleens were
prepared as previously described [19]. Digital images were
captured, overlaid, and processed with the Confocal and LCS
Lite programs (Leica).
Cell isolation and Quantitative PCR
Plasma cells were isolated via negative selection (B2202DX52
cells) and subsequent positive selection (CD138+ cells) using
magnetic beads and following manufacturer’s instructions (Milte-
nyi). RNA was extracted and cDNA was generated as previously
described [19]. Primers and probes for running a TaqMan
quantitative PCR (qPCR) assay were purchased from Applied
Biosystems. TaqMan gene expression assays included Xbp1:
Mm00457357_m1, Prdm1: Mm00476128_m1, Bcl6:
Mm00477633_m1; and Irf4: Mm00516431_m1. Reaction param-
eters were as previously described [17]. Results were analyzed with
iQ5 real-time PCR software (version 2.0).
ELISA
For total IgM and IgG1 ELISAs, samples were serially diluted
and added to 96-well plates (50 mL/well) pre-coated with 5 mg/
mL of goat-anti IgM and IgG, respectively (Southern Biotech). For
standard curve, normal mouse IgM and IgG1 (Southern Biotech)
were used. After incubation at 37uC for 1 h, bound Abs were
revealed by goat-anti-IgM-AP and goat-anti-IgG1-AP, respective-
ly (Southern Biotech). Total IgE ELISA was carried out as
previously described [45]. For antigen-specific ELISAs, ELISA
was carried out as described with minor modifications. Plates were
coated with NP14BSA (Biosearch Technologies)(15 mg/mL in
PBS) for samples and with 5 mg/mL of goat-anti Ig (Southern
Biotech) in BBS for standard. Standard curves were performed by
coating with anti- IgM, anti-IgG1 or IgG3 and adding known
amounts of IgM, IgG1 or IgG3, respectively. The values for
experimental samples are reflected as relative units (RU) because
serum antigen-specific Abs were captured with antigen. The
remaining steps were carried out as described.
Statistical analysis
p-values were calculated using unpaired two-tailed Student’s t
tests in Graphpad Prism v5. Error bars represent the SEM
between samples. p,0.05 is considered statistically significant.
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